Athlete′s Foot Drugs Market Size, Share, Regional Analysis by 2030

Athlete's foot, also known as tinea pedis, is a type of viral infection of the fungus which affects the feet. This can spread to the toe nails and hands. It is more commonly seen in athletes, hence the name. The infection can cause scaling, itching, and blisters on the soles and sides of the feet. Athlete's foot drugs involves medications which are used to treat this condition. It includes antifungal medications such as terbinafine (Lamisil) and itraconazole (Sporanox), as well as topical corticosteroids such as betamethasone (Dermovate). These drugs help to clear up the infection and relieve symptoms.

The global athlete′s foot drugs market is expected to witness significant growth during the forecast period. According to National Center for Biotechnology Information (NCBI) records, an athlete's foot is very common with an occurence rate of an estimated 3 to 15% of the population. Oral segment witnessed to have a huge growth and is readjusted to a revised 2.9% CAGR for the next 7-year period. The athlete's foot drug is used to treat fungal infection of the feet, which causes the scaling and blistering of the soles, fissures at toes, and painful and burning sensations along itching rashes.

Data Bridge Market Research analyses a growth rate in the global athlete′s foot drugs market in the forecast period 2023-2030. The expected CAGR of global athlete′s foot drugs market is tend to be around 6% in the mentioned forecast period. The market was valued at USD 0.94 billion in 2022, and it would grow upto USD 1.5 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

North America is dominating the market due to easy access to healthcare facilities and increased investments in healthcare by leading market players.

Request a Sample Copy @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-athletes-foot-drugs-market

Asia-Pacific is considered to have the most lucrative period due to the developing healthcare facilities, large number of generic manufacturer and rise in government initiatives.

Key players operating in the global athlete′s foot drugs market include:

About Data Bridge Market Research, Private Ltd

Data Bridge Market Research Pvt Ltd is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.

Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expands their reach by opening a new office in Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. “Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated Team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve.”

Contact: 

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Corporatesales@databridgemarketresearch.com

Article source: https://article-realm.com/article/Sports-Recreation/43739-Athlete-s-Foot-Drugs-Market-Size-Share-Regional-Analysis-by-2030.html